Topic: personalized treatments
Pact Pharma launched a phase 1 trial of a technology designed to attack solid tumors with CAR-T cells tailored to individual patients.
José Baselga, AstraZeneca's R&D chief, discussed capivasertib, how to pick the best drug for patients and what needs to change before cancer is cured.
Some microRNAs could serve as prognostic markers of Crohn's and open the possibility of developing personalized therapies.
After raising more than $194 million in venture capital, Gritstone is looking to raise up to $80 million in its IPO.
Ovarian cancer has proved resistant to immunotherapy, but may be vulnerable to personalized T cell therapy using tumor-derived T cells.
IBM and Illumina have joined an initiative to enable personalized leukemia treatment strategies.
Advaxis and Amgen get an FDA OK to start testing their neoantigen cancer vaccine, partnered in a $540 million deal last year.